Abeona Therapeutics (ABEO) Current Assets (2010 - 2026)

Abeona Therapeutics' Current Assets history runs 17 years deep, the most recent figure standing at $183.0 million for Q1 2026.

• In Q1 2026, Current Assets rose 107.65% year-over-year to $183.0 million; the TTM figure through Mar 2026 stood at $183.0 million (up 107.65% YoY), while the FY2025 annual figure was $204.9 million, up 103.17% from the prior year.
• Current Assets was $183.0 million for Q1 2026 at Abeona Therapeutics, down from $204.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $232.3 million in Q2 2025 to a low of $25.5 million in Q3 2022.
• Historically, Current Assets has averaged $98.7 million across 5 years, with a median of $66.7 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Current Assets sank 62.45% in 2022, then jumped 185.9% in 2024.
• A 5-year view of Current Assets shows it stood at $53.1 million in 2022, then gained by 4.97% to $55.7 million in 2023, then jumped by 80.94% to $100.9 million in 2024, then surged by 103.17% to $204.9 million in 2025, then fell by 10.7% to $183.0 million in 2026.
• The last three Current Assets figures came in at $183.0 million (Q1 2026), $204.9 million (Q4 2025), and $216.1 million (Q3 2025), per Business Quant data.